miRNA dysregulation is an emerging modulator of genomic instability
Genomic instability consists of a range of genetic alterations within the genome that
contributes to tumor heterogeneity and drug resistance. It is a well-established characteristic …
contributes to tumor heterogeneity and drug resistance. It is a well-established characteristic …
Can microRNA become next-generation tools in molecular diagnostics and therapeutics? A systematic review
V Saini, R Dawar, S Suneja, S Gangopadhyay… - Egyptian Journal of …, 2021 - Springer
Background MicroRNAs (miRNAs) represent a novel class of single-stranded RNA
molecules of 18–22 nucleotides that serve as powerful tools in the regulation of gene …
molecules of 18–22 nucleotides that serve as powerful tools in the regulation of gene …
[HTML][HTML] MiR-155-5p exerts tumor-suppressing functions in Wilms tumor by targeting IGF2 via the PI3K signaling pathway
X Luo, J Dong, X He, L Shen, C Long, F Liu… - Biomedicine & …, 2020 - Elsevier
Abstract Background MicroRNA-155-5p (miR-155-5p) has been reported to play an
oncogenic role in different human malignancies; however, its role in Wilms tumor (WT) …
oncogenic role in different human malignancies; however, its role in Wilms tumor (WT) …
Role of microRNAs in Chronic Lymphocytic Leukemia
F Autore, A Ramassone, L Stirparo, S Pagotto… - International Journal of …, 2023 - mdpi.com
Chronic Lymphocytic Leukemia (CLL) is the most common form of leukemia in adults, with a
highly variable clinical course. Improvement in the knowledge of the molecular pathways …
highly variable clinical course. Improvement in the knowledge of the molecular pathways …
MicroRNAs in autoimmunity and hematological malignancies
MD Marco, A Ramassone, S Pagotto… - International Journal of …, 2018 - mdpi.com
Autoimmunity and hematological malignancies are often concomitant in patients. A causal
bidirectional relationship exists between them. Loss of immunological tolerance with …
bidirectional relationship exists between them. Loss of immunological tolerance with …
Biosafety evaluation of culture-expanded human chondrocytes with growth factor cocktail: a preclinical study
The scarcity of chondrocytes is a major challenge for cartilage tissue engineering.
Monolayer expansion is necessary to amplify the limited number of chondrocytes needed for …
Monolayer expansion is necessary to amplify the limited number of chondrocytes needed for …
Role of non-coding RNAs in the development of targeted therapy and immunotherapy approaches for chronic lymphocytic leukemia
In the past decade, novel targeted therapy approaches, such as BTK inhibitors and Bcl2
blockers, and innovative treatments that regulate the immune response against cancer cells …
blockers, and innovative treatments that regulate the immune response against cancer cells …
Role of microRNAs in Chronic Lymphocytic Leukemia.
A Ramassone, L Stirparo, S Pagotto… - International …, 2023 - search.ebscohost.com
Abstract Chronic Lymphocytic Leukemia (CLL) is the most common form of leukemia in
adults, with a highly variable clinical course. Improvement in the knowledge of the molecular …
adults, with a highly variable clinical course. Improvement in the knowledge of the molecular …
HNRNPL Restrains miR-155 Targeting of BUB1 to Stabilize Aberrant Karyotypes of Transformed Cells in Chronic Lymphocytic Leukemia
S Pagotto, A Veronese, A Soranno, V Balatti… - Cancers, 2019 - mdpi.com
Aneuploidy and overexpression of hsa-miR-155-5p (miR-155) characterize most solid and
hematological malignancies. We recently demonstrated that miR-155 sustains aneuploidy at …
hematological malignancies. We recently demonstrated that miR-155 sustains aneuploidy at …
Identification of microRNA editing sites in three subtypes of leukemia
W Xie, J Yang, N Zhou, H Ding, G Zhou… - Frontiers in Molecular …, 2022 - frontiersin.org
Leukemia is an aberrant hyper-proliferation of immature blood cells that do not form solid
tumors. The transcriptomes of microRNAs (miRNAs) of leukemia have been intensively …
tumors. The transcriptomes of microRNAs (miRNAs) of leukemia have been intensively …